Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1613 1645 1675
This examiner grants 65% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18317071 | PROBIOTIC COMPOSITIONS AND USES THEREOF | Non-Final OA | The University of British Columbia |
| 17531058 | VACCINE COMPOSITIONS FOR CLOSTRIDIUM DIFFICILE | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18703879 | METHODS AND COMPOSITION FOR THE TREATMENT OF PRADER-WILLI SYNDROME SYMPTOMS | Non-Final OA | The General Hospital Corporation |
| 18343968 | NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOF | Final Rejection | PFIZER INC. |
| 18005444 | COMPOSITIONS AND METHODS RELATING TO TYPHOID TOXIN SUBUNIT PLTC | Final Rejection | YALE UNIVERSITY |
| 17786121 | METHODS AND COMPOSITIONS FOR DIAGNOSIS OF TUBERCULOSIS | Final Rejection | The Brigham and Women's Hospital, Inc. |
| 17909423 | LIVE SALMONELLA TYPHI VECTORS ENGINEERED TO EXPRESS PROTEIN ANTIGENS AND METHODS OF USE THEREOF | Final Rejection | National Research Council of Canada |
| 18714926 | LACTOBACILLI FOR SKIN AGING | Non-Final OA | INTERNATIONAL N&H DENMARK APS |
| 18273297 | COMPOSITION FOR SUPPRESSING DETERIORATION OF OR ENHANCING MEMORY LEARNING FUNCTION AND/OR COGNITIVE FUNCTION | Final Rejection | DIC Corporation |
| 17759045 | IMMUNOLOGICALLY OPTIMIZED BOTULINUM TOXIN LIGHT CHAIN VARIANTS | Final Rejection | CHILDREN'S MEDICAL CENTER CORPORATION |
| 17929415 | NEISSERIA MENINGITIDIS IMMUNOGENIC COMPOSITIONS | Non-Final OA | THE U.S.A, as represented by the Secretary, Department of Health and Human Services |
| 18286133 | PROBIOTIC COMPOSITIONS AND USES THEREOF | Non-Final OA | SUPERBREWED FOOD, INC. |
| 18626627 | MICROBIOME TREATMENTS FOR ANIMAL FERTILITY | Non-Final OA | VYTELLE LLC |
| 18578106 | BIFIDOBACTERIA FOR PREVENTING, REDUCING OR TREATING SKIN AGING | Non-Final OA | DUPONT NUTRITION BIOSCIENCES APS |
| 18035766 | COMPOSITION COMPRISING AKKERMANSIA MUCINIPHILA AND GREEN TEA EXTRACT | Final Rejection | THE AKKERMANSIA COMPANY |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy